![Jesper Høiland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesper Høiland
Presidente presso
SCIBASE HOLDING AB (PUBL)
Patrimonio netto: 30 250 $ in data 31/07/2026
Profilo
Jesper Høiland is currently Chairman at SciBase Holding AB since 2024.
Mr. Høiland is Independent Director at ALK-Abello A since 2023.
Mr. Høiland is Independent Director at Allarity Therapeutics, Inc. starting 2025.
Mr. Høiland is Head-Strategy at Rani Therapeutics Holdings, Inc. starting 2026.
Formerly, Mr. Høiland was President, Chief Executive Officer & Director at Radius Health, Inc. from 2017 to 2020.
Mr. Høiland was Global Chief Commercial Officer & Senior VP at Ascendis Pharma A from 2020 to 2022.
Mr. Høiland was Senior Vice President-International Operations at Novo Nordisk A from 2004 to 2012.
Mr. Høiland was President at Novo Nordisk, Inc. from 2013 to 2017.
Mr. Høiland was Director at Pharmaceutical Research & Manufacturers of America from 2014 to 2016.
Mr. Høiland was Management Consultant at Liseberg AB from 1985 to 1987.
Mr. Høiland held roles as Independent Director at Concert Pharmaceuticals, Inc., Director at LEO Pharma A, General Manager at Novo Nordisk Pharmaceuticals Pty Ltd., and Senior Vice President at Novo Nordisk North America, Inc. Mr. Høiland graduated from Copenhagen Business School in 1985.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/01/2026 | 25.000 ( 0,16% ) | 30 250 $ | 31/07/2026 |
Posizioni attive di Jesper Høiland
| Società | Posizione | Inizio |
|---|---|---|
| ALK-ABELLÓ A/S | Direttore/Membro del Consiglio | 01/01/2023 |
| SCIBASE HOLDING AB (PUBL) | Presidente | 13/06/2024 |
| ALLARITY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 30/06/2025 |
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 25/03/2026 |
Precedenti posizioni note di Jesper Høiland
| Società | Posizione | Fine |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 23/05/2022 |
| RADIUS HEALTH, INC. | Amministratore Delegato | 28/04/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Presidente | 01/03/2017 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | 01/01/2016 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2012 |
Formazione di Jesper Høiland
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
ALK-Abello A/S
 ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
SciBase Holding AB
 SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Novo Nordisk North America, Inc. | |
Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
Allarity Therapeutics, Inc.
 Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
